{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:06:08Z","timestamp":1793739968630,"version":"4.6.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015223","name":"Danish Diabetes Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18CC0034900"],"award-info":[{"award-number":["NNF18CC0034900"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["0134-00217B"],"award-info":[{"award-number":["0134-00217B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.molmet.2022.101581","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T02:25:30Z","timestamp":1661221530000},"page":"101581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"special_numbering":"C","title":["MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives"],"prefix":"10.1016","volume":"65","author":[{"given":"Mette Yde","family":"Hochreuter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Dall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas T.","family":"Treebak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-519X","authenticated-orcid":false,"given":"Romain","family":"Barr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A\u00a0global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhepr.2019.08.002","article-title":"Non-alcoholic fatty liver disease in lean individuals","volume":"1","author":"Albhaisi","year":"2019","journal-title":"JHEP Reports"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/diagnostics12020407","article-title":"Diagnostic modalities of non-alcoholic fatty liver disease: from biochemical biomarkers to multi-omics non-invasive approaches","volume":"12","author":"Martinou","year":"2022","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib7","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2022.101581_bib8","article-title":"Non-alcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","author":"Pafili","year":"2020","journal-title":"Molecular Metabolism"},{"issue":"8","key":"10.1016\/j.molmet.2022.101581_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2022.101581_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2022.101581_bib13","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","author":"Huby","year":"2021","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-019-0044-9","article-title":"Liver macrophages regulate systemic metabolism through non-inflammatory factors","volume":"1","author":"Morgantini","year":"2019","journal-title":"Nature Metabolism"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib15","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"issue":"5858","key":"10.1016\/j.molmet.2022.101581_bib17","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.molmet.2022.101581_bib18","first-page":"3562","article-title":"miR-322 stabilizes MEK1 expression to inhibit RAF\/MEK\/ERK pathway activation in cartilage","volume":"144","author":"Bluhm","year":"2017","journal-title":"Development"},{"issue":"7256","key":"10.1016\/j.molmet.2022.101581_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molmet.2022.101581_bib20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/hepr.13419","article-title":"Identification of two microRNA nodes as potential cooperative modulators of liver metabolism","volume":"49","author":"Hochreuter","year":"2019","journal-title":"Hepatology Research"},{"issue":"12","key":"10.1016\/j.molmet.2022.101581_bib21","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/MCB.01189-10","article-title":"A\u00a0KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context","volume":"31","author":"Lin","year":"2011","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/cvr\/cvq010","article-title":"MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism","volume":"86","author":"Lu","year":"2010","journal-title":"Cardiovascular Research"},{"issue":"20","key":"10.1016\/j.molmet.2022.101581_bib23","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1073\/pnas.1105401108","article-title":"Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs)","volume":"108","author":"Mortensen","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.molmet.2022.101581_bib24","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.4049\/jimmunol.0903463","article-title":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages","volume":"184","author":"Murphy","year":"2010","journal-title":"Journal of Immunology"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/cdd.2014.206","article-title":"Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells","volume":"22","author":"Yu","year":"2015","journal-title":"Cell Death & Differentiation"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2014.05.047","article-title":"MicroRNA directly enhances mitochondrial translation during muscle differentiation","volume":"158","author":"Zhang","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2008.05.001","article-title":"MicroRNA-10a binds the 5\u2019UTR of ribosomal protein mRNAs and enhances their translation","volume":"30","author":"\u00d8rom","year":"2008","journal-title":"Molecular Cell"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in control of gene expression: an overview of nuclear functions","volume":"17","author":"Catalanotto","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genomics, Proteomics & Bioinformatics"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.12661","article-title":"Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease","volume":"4","author":"Soronen","year":"2016","journal-title":"Physiological Reports"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ijo.2017.21","article-title":"Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD","volume":"4121","author":"Latorre","year":"2017","journal-title":"International Journal of Obesity"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trsl.2015.04.014","article-title":"High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis","volume":"166","author":"Leti","year":"2015","journal-title":"Translational Research"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib34","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00535-016-1178-0","article-title":"A\u00a0micro-RNA expression signature for human NAFLD progression","volume":"51","author":"Guo","year":"2016","journal-title":"Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"MiR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"17","key":"10.1016\/j.molmet.2022.101581_bib37","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A\u00a0pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"Lee","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/aps.2014.116","article-title":"Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis","volume":"36","author":"Jiao","year":"2015","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.molmet.2022.101581_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101244","article-title":"Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease","volume":"51","author":"Xu","year":"2021","journal-title":"Molecular Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7150\/ijbs.19370","article-title":"Emerging roles of SIRT1 in fatty liver diseases","volume":"13","author":"Ding","year":"2017","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.molmet.2022.101581_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.196","article-title":"Activation of the SIRT1\/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease","volume":"6","author":"Shan","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib42","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2022.101581_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPARalpha expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2022.101581_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8466","article-title":"A\u00a0metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.molmet.2022.101581_bib46","article-title":"LXR\u03b1 activation inhibits autophagy and lipophagy in hepatocytes by dysregulating ATG4B and Rab-8B, reducing mitochondrial fuel oxidation","author":"Kim","year":"2020","journal-title":"Hepatology: Hep."},{"issue":"530","key":"10.1016\/j.molmet.2022.101581_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao4617","article-title":"IRE1alpha prevents hepatic steatosis by processing and promoting the degradation of select microRNAs","volume":"11","author":"Wang","year":"2018","journal-title":"Science Signaling"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib48","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1128\/MCB.00420-13","article-title":"c-Jun N-terminal kinase 1\/c-Jun activation of the p53\/microRNA 34a\/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver","volume":"34","author":"Ferreira","year":"2014","journal-title":"Molecular and Cellular Biology"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158657","article-title":"Activation of the miR-34a\/SIRT1\/p53 signaling pathway contributes to the progress of liver fibrosis via inducing apoptosis in hepatocytes but not in HSCs","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.molmet.2022.101581_bib50","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/bph.14573","article-title":"Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a\/Sirt1\/p53 and TGF-\u03b21\/Smads signalling","volume":"176","author":"Song","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"26","key":"10.1016\/j.molmet.2022.101581_bib51","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.3748\/wjg.v23.i26.4661","article-title":"Can a fibrotic liver afford epithelial-mesenchymal transition?","volume":"23","author":"Munker","year":"2017","journal-title":"World Journal of Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2020.02.025","article-title":"Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis","volume":"73","author":"Liu","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib53","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170926","article-title":"PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of miR-34a and miR-29c in hepatic stellate cells","volume":"37","author":"Liu","year":"2017","journal-title":"Bioscience Reports"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.201700612r","article-title":"SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice","volume":"32","author":"Li","year":"2018","journal-title":"Federation of American Societies for Experimental Biology Journal"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","article-title":"MicroRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor \u03b3","volume":"11","author":"Li","year":"2015","journal-title":"Molecular Medicine Reports"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","article-title":"Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma","volume":"19","author":"Hou","year":"2011","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","article-title":"MiR-122 in hepatic function and liver diseases","volume":"3","author":"Hu","year":"2012","journal-title":"Protein Cell"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib59","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver International"},{"issue":"8","key":"10.1016\/j.molmet.2022.101581_bib60","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.molmet.2022.101581_bib61","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in\u00a0vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metabolism"},{"issue":"7068","key":"10.1016\/j.molmet.2022.101581_bib63","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in\u00a0vivo with \u201cantagomirs","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib64","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2017.08.013","article-title":"Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues","volume":"153","author":"Chai","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib65","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA attenuates nonalcoholic fatty liver progression in mice via up-regulation of microRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"MiR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Molecular Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib67","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1159\/000485765","article-title":"MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via Yin Yang 1","volume":"44","author":"Wu","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.molmet.2022.101581_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2020.06.015","article-title":"Upregulation of RelB in the miR-122 knockout mice contributes to increased levels of proinflammatory chemokines\/cytokines in the liver and macrophages","volume":"226","author":"Hsu","year":"2020","journal-title":"Immunology Letters"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib69","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1038\/s41598-019-43928-7","article-title":"The differential expression of Cide family members is sssociated with Nafld progression from steatosis to steatohepatitis","volume":"9","author":"Sans","year":"2019","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib70","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/hep.25912","article-title":"Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid","volume":"56","author":"Yang","year":"2012","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib71","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/jcb.25188","article-title":"HCBP6 modulates triglyceride homeostasis in hepatocytes via the SREBP1c\/FASN Pathway","volume":"116","author":"Gao","year":"2015","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib72","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.celrep.2015.12.023","article-title":"Reciprocal regulation between SIRT6 and miR-122 controls liver metabolism and predicts hepatocarcinoma prognosis","volume":"14","author":"Elhanati","year":"2016","journal-title":"Cell Reports"},{"issue":"12","key":"10.1016\/j.molmet.2022.101581_bib73","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1261\/rna.063099.117","article-title":"Precursor microRNA-122 inhibits synthesis of Insig1 isoform mRNA by modulating polyadenylation site usage","volume":"23","author":"Norman","year":"2017","journal-title":"RNA"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib74","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","article-title":"MiR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression","volume":"58","author":"Li","year":"2013","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2022.101581_bib75","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00109-017-1586-5","article-title":"NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6","volume":"95","author":"Yu","year":"2017","journal-title":"Journal of Molecular Medicine"},{"issue":"14","key":"10.1016\/j.molmet.2022.101581_bib76","doi-asserted-by":"crossref","first-page":"12224","DOI":"10.18632\/oncotarget.3652","article-title":"Identification of a novel TGF-\u03b2-miR-122-fibronectin 1\/serum response factor signaling cascade and its implication in hepatic fibrogenesis","volume":"6","author":"Zeng","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib77","first-page":"1","article-title":"Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression","volume":"10","author":"Du","year":"2020","journal-title":"CMGH"},{"key":"10.1016\/j.molmet.2022.101581_bib78","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2020.01.003","article-title":"Regulation of hepatic glutamine metabolism by miR-122","volume":"34","author":"Sengupta","year":"2020","journal-title":"Molecular Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver \u2013 linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111738","article-title":"Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p","volume":"387","author":"Zhao","year":"2020","journal-title":"Experimental Cell Research"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31835-2","article-title":"Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in\u00a0vitro and in\u00a0vivo model","volume":"8","author":"Belloni","year":"2018","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.molmet.2022.101581_bib83","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21\u2217 in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2022.101581_bib84","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death & Disease"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib86","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s11095-011-0473-y","article-title":"PPARalpha is regulated by miR-21 and miR-27b in human liver","volume":"28","author":"Kida","year":"2011","journal-title":"Pharmaceutical Research"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib87","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/ajpgi.00346.2014","article-title":"Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis","volume":"308","author":"Dattaroy","year":"2015","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"issue":"52","key":"10.1016\/j.molmet.2022.101581_bib88","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The autoregulatory feedback loop of MicroRNA-21\/programmed cell death protein 4\/Activation protein-1 (MiR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development","volume":"288","author":"Zhang","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib89","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.29627","article-title":"MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis","volume":"67","author":"Caviglia","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108005","article-title":"MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib91","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib92","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543784.2020.1718105","article-title":"Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair","volume":"29","author":"Jarman","year":"2020","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib93","first-page":"2201","article-title":"Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT\/\u03b2-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease","volume":"44","author":"Wang","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.molmet.2022.101581_bib94","article-title":"An endoplasmic reticulum stress-microRNA-26a feedback circuit in NAFLD","volume":"31428","author":"Xu","year":"2020","journal-title":"Hepatology: Hep"},{"issue":"11","key":"10.1016\/j.molmet.2022.101581_bib95","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/mnfr.201300071","article-title":"Fisetin protects against hepatosteatosis in mice by inhibiting miR-378","volume":"57","author":"Jeon","year":"2013","journal-title":"Molecular Nutrition & Food Research"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib96","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/hep.30301","article-title":"LXRalpha promotes hepatosteatosis in part through activation of microRNA-378 transcription and inhibition of Ppargc1beta expression","volume":"69","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib97","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","article-title":"MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-\u03baB-TNF\u03b1 pathway","volume":"70","author":"Zhang","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2022.101581_bib98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.metabol.2018.03.023","article-title":"A\u00a0negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet","volume":"85","author":"Zhang","year":"2018","journal-title":"Metabolism, Clinical and Experimental"},{"issue":"532","key":"10.1016\/j.molmet.2022.101581_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9709","article-title":"Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance","volume":"12","author":"Azzimato","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/j.gastro.2021.08.030","article-title":"Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity","volume":"161","author":"Azzimato","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib101","first-page":"646","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma","volume":"1","author":"Povero","year":"2015","journal-title":"CMGH"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib102","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","article-title":"Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells","volume":"7","author":"Lee","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib103","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through Rictor\/Akt\/Forkhead Box Transcription Factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2022.101581_bib104","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib105","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI122258","article-title":"Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223","volume":"129","author":"Calvente","year":"2019","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.molmet.2022.101581_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141513","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","volume":"131","author":"He","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2022.101581_bib107","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nature Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib108","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"issue":"48","key":"10.1016\/j.molmet.2022.101581_bib109","doi-asserted-by":"crossref","first-page":"12158","DOI":"10.1073\/pnas.1808855115","article-title":"Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice","volume":"115","author":"Casta\u00f1o","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib110","article-title":"Liver governs adipose remodelling via extracellular vesicles in response to lipid overload","volume":"11","author":"Zhao","year":"2020","journal-title":"Nature Communications"},{"issue":"7642","key":"10.1016\/j.molmet.2022.101581_bib111","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature21365","article-title":"Adipose-derived circulating miRNAs regulate gene expression in other tissues","volume":"542","author":"Thomou","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib112","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose tissue macrophage-derived exosomal miRNAs can modulate in\u00a0vivo and in\u00a0vitro insulin sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib113","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/obr.12765","article-title":"Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation","volume":"20","author":"Baranova","year":"2019","journal-title":"Obesity Reviews"},{"issue":"17","key":"10.1016\/j.molmet.2022.101581_bib114","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1042\/CS20190558","article-title":"Exosomal microRNA-122 mediates obesity-related cardiomyopathy through suppressing mitochondrial ADP-ribosylation factor-like 2","volume":"133","author":"Wang","year":"2019","journal-title":"Clinical Science"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib115","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-020-01334-8","article-title":"Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"20","author":"Xin","year":"2020","journal-title":"BMC Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib116","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep4.1445","article-title":"Circulating MicroRNA-122 and fibrosis stage predict mortality of Japanese patients with histopathologically confirmed NAFLD","volume":"4","author":"Akuta","year":"2020","journal-title":"Hepatology Communications"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib117","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep4.1501","article-title":"Differential associations of circulating microRNAs with pathogenic factors in NAFLD","volume":"4","author":"Ezaz","year":"2020","journal-title":"Hepatology Communications"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib118","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40290-019-00305-z","article-title":"Applying non-invasive fibrosis measurements in NAFLD\/NASH: progress to date","volume":"33","author":"Albhaisi","year":"2019","journal-title":"Pharmaceutical Medicine"},{"issue":"7","key":"10.1016\/j.molmet.2022.101581_bib119","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/jcm9072032","article-title":"Role of extracellular vesicles in the pathophysiology, diagnosis and tracking of non-alcoholic fatty liver disease","volume":"9","author":"Newman","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cpt.2244","article-title":"Exploring the use of serum-derived small extracellular vesicles as liquid biopsy to study the induction of hepatic cytochromes P450 and organic anion transporting polypeptides","volume":"110","author":"Rodrigues","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics (St. Louis)"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010195","article-title":"Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease","volume":"10","author":"Newman","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.molmet.2022.101581_bib122","first-page":"1","article-title":"A\u00a0blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"1253","author":"Harrison","year":"2020","journal-title":"The Lancet Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.molmet.2022.101581_bib124","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"issue":"8","key":"10.1016\/j.molmet.2022.101581_bib125","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.molmet.2022.101581_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.molmet.2022.101581_bib127","author":"Regulus Therapeutics Inc"},{"issue":"7353","key":"10.1016\/j.molmet.2022.101581_bib128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2022.101581_bib129","author":"Regulus Therapeutics Inc"},{"issue":"18","key":"10.1016\/j.molmet.2022.101581_bib130","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00018-019-03136-y","article-title":"MicroRNA expression studies: challenge of selecting reliable reference controls for data normalization","volume":"76","author":"Madadi","year":"2019","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"5","key":"10.1016\/j.molmet.2022.101581_bib131","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/cancers12051290","article-title":"Molecular mechanisms regulating obesity-associated hepatocellular carcinoma","volume":"12","author":"Rajesh","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ar.23954","article-title":"Role of microRNAs in the development of hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"302","author":"Zhang","year":"2019","journal-title":"The Anatomical Record"},{"issue":"1","key":"10.1016\/j.molmet.2022.101581_bib133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Research"},{"issue":"8","key":"10.1016\/j.molmet.2022.101581_bib134","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/gb-2007-8-8-r166","article-title":"The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression","volume":"8","author":"Hon","year":"2007","journal-title":"Genome Biology"},{"issue":"6","key":"10.1016\/j.molmet.2022.101581_bib135","first-page":"1002","article-title":"miRNA-miRNA crosstalk: from genomics to phenomics","volume":"18","author":"Xu","year":"2017","journal-title":"Briefings in Bioinformatics"},{"issue":"2","key":"10.1016\/j.molmet.2022.101581_bib136","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:21:18Z","timestamp":1778851278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877822001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":136,"alternative-id":["S2212877822001508"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101581","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101581"}}